FDA Approved: LENALIDOMIDE — Original Application (EXELAN PHARMACEUTICALS INC.)

View source ↗

Summary

The FDA approved Exelan Pharmaceuticals Inc.'s original application for lenalidomide, granting approval of a generic version of the cancer drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome with 5q Deletion
• Small Lymphocytic Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

ORIG AP for LENALIDOMIDE (LENALIDOMIDE)